Medicine, Health & Food
Volume: 98 , Issue: 1 , April Published Date: 11 April 2022
Publisher Name: IJRP
Views: 526 , Download: 367 , Pages: 142 - 150
DOI: 10.47119/IJRP100981420223030
Publisher Name: IJRP
Views: 526 , Download: 367 , Pages: 142 - 150
DOI: 10.47119/IJRP100981420223030
Authors
# | Author Name |
---|---|
1 | Dewa Ayu Mas Shintya Dewi |
2 | Nyoman Bendhesa Wirananggala |
3 | Dewa Gede Sahabisheka Dewanta |
Abstract
Background: Corona Virus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), was labeled a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO) on January 30, 2020. SARS-CoV-2, a new type of enveloped RNA RNA virus, can be transmitted from human to human through droplets and contact. As of May 27, 2020, more than 5.6 million confirmed cases have been documented globally, with over 350,000 deaths. Anatomical, physiological changes in pregnancy, especially in the cardiorespiratory system, make pregnant women more susceptible to COVID-19 infection and cause more serious complications. Severe ARDS is a form of manifestation that often occurs in the peripartum period. Severe complications in pregnancy such as premature birth, fetal death in utero, intensive care unit have been reported. Case: A 31 Year old female with 3rd pregnancy, 26-27 weeks of gestation, accompanied by a locus minoris, a former cesarean section infected with severe COVID-19 with ARDS, complaining of reduced fetal movement after undergoing treatment in the covid isolation room for 24 hours and successful management of anesthesia with regional subarachnoid block anesthesia. Conclusion: In perioperative management, especially in optimizing the cardiorespiratory system, professionals in anesthetic management and multidisciplinary cooperation are important in managing this patient.